Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/18332
Title: Neurobehavioral Impairment and CPAP Treatment Response in Mild-Moderate Obstructive Sleep Apneas.
Authors: Jackson, Melinda L;McEvoy, R Doug;Banks, Siobhan;Barnes, Maree
Affiliation: Department of Medicine, The University of Melbourne, Victoria, Australia
Centre for Sleep Research, University of South Australia, Adelaide, Australia
Institute for Breathing and Sleep, Austin Health, Heidelberg, Victoria, Australia
School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria, Australia
Adelaide Institute for Sleep Health: Flinders Centre of Research Excellence Flinders University, Bedford Park, South Australia, Australia
Issue Date: 15-Jan-2018
EDate: 2018-01-15
Citation: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2018; 14(1): 47-56
Abstract: The degree of neurobehavioral impairment and treatment response in mild-moderate obstructive sleep apnea (OSA) compared to that of an appropriate control group are unclear. This study compared neurobehavioral function and response to continuous positive airway pressure (CPAP) treatment in patients with mild to moderate OSA with those of a non-sleep apneic community sample of similar demography. One hundred ten patients with OSA and 31 asymptomatic community dwellers underwent overnight polysomnography and neurobehavioral testing. Participants with OSA (n = 88) were treated with CPAP for 3 months, and repeat evaluations were performed at the end of the treatment period. Compared to the community sample, participants with OSA were significantly sleepier, had impaired mood and quality of life, and showed decrements in neuropsychological function, specifically psychomotor function, working memory and vigilance. Some neuropsychological and mood outcomes were normalized with CPAP, but significant decrements persisted in most outcomes even in those participants with adequate device usage. Patients with mild to moderate OSA have significant neurobehavioral morbidity. During "gold standard" treatment, normal function was not achieved, even with adequate device usage. CPAP efficacy for improving sleepiness and neuropsychological function in this milder end of the OSA spectrum may be poor, which may affect CPAP adherence. These findings suggest that there may be neurological changes related to OSA that do not respond to CPAP treatment, the etiology of which requires further investigation.
URI: http://ahro.austin.org.au/austinjspui/handle/1/18332
DOI: 10.5664/jcsm.6878
PubMed URL: 29198304
Type: Journal Article
Subjects: continuous positive airway pressure
neuropsychological function
obstructive sleep apnea
quality of life
sleepiness
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.